Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
about
Indoxyl Sulfate-Review of Toxicity and Therapeutic StrategiesThe microbiota and chronic kidney diseases: a double-edged swordThe systemic nature of CKD.Gut microbiome and kidney disease: a bidirectional relationship.Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individualsp-Cresyl Sulfate.Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.Gut microbiome in chronic kidney disease: challenges and opportunities.Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.Prebiotics, Prosynbiotics and Synbiotics: Can They Reduce Plasma Oxidative Stress Parameters? A Systematic Review.Effect of a Short-Course Treatment with Synbiotics on Plasma p-Cresol Concentration in Kidney Transplant Recipients.Intestinal metabolites, chronic kidney disease and renal transplantation: Enigma Variations?Protein-controlled versus restricted protein versus low protein diets in managing patients with non-dialysis chronic kidney disease: a single centre experience in AustraliaEffect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD.Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patientsBiochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.Beyond Sodium, Phosphate and Potassium: Potential Dietary Interventions in Kidney Disease.Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease.Gut Microbiome in Chronic Kidney Disease.Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD.Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.Probiotics, prebiotics and synbiotics for chronic kidney disease: protocol for a systematic review and meta-analysisThe Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal DisordersInflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and OutcomeGut Microbiota and Cardiovascular Uremic ToxicitiesBiotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis
P2860
Q28075033-EA3DE6C2-B00F-4631-84A1-55CB16941C28Q28078306-44025E6A-ADDC-4208-96AB-3C126B344B92Q30234695-60BC7F46-5ECD-4717-A9DF-77D0814F94B3Q33586234-3B2AB715-BB11-4E3E-985A-5D750FB6184EQ33749467-DDB78F2C-1B09-43F6-90D2-F437B72A9D6FQ37596259-DA5B9876-DF3C-4094-B1C4-1AB1EF200A38Q37672982-FDEFD801-6B63-4666-8A67-329823C0CC86Q38636372-2D84EA35-795C-4593-8BF7-EEF06CDE1F08Q38836354-D8FD3D15-8B88-4B3F-AF36-85D15A805C41Q38921854-BDC5A4EF-AF91-4633-9CBE-8BDA5BFCE4E5Q39065306-AAC8DCE4-8C66-4F89-BCE4-1F1700C82531Q40051571-1C80B611-D768-461A-8533-7D0C1F9C2511Q40749194-DF171E8C-32A5-4A43-A8BD-FAE2ED8FDDA7Q42395408-5EB55050-1C7A-431A-8DCF-C0F0969D6915Q42551130-35C4769D-2629-4E13-85E8-CCA449A8D319Q42706652-D701CCB0-4CD5-4759-B719-0FC28E7DE2DBQ47216784-CFDACD76-8AE2-4851-9BEB-A70617B02FF0Q47899492-B8C37E34-8457-4913-A00A-FE80DC25E21EQ48366548-B9A6E1F0-6931-473D-A360-9CECC663227CQ50108575-F45BDB35-1EAA-4061-95F4-79E214E6DF06Q51121348-158BE955-5D2E-4152-B559-8D99270164A0Q51732046-DE741BC8-448E-4CA0-AEE6-7203A1A86BC3Q52589945-17C2C694-68E6-40A1-8F75-F64B6C3DBF1EQ52680146-8B6EB3E4-82F1-4E9A-A823-1BF6AF1888A8Q54233821-1FB32C2E-5028-4A35-A4E2-9950555B74B6Q55279804-8C9D3A7A-BA79-49B3-A217-5DA3CC5B8F5DQ55476982-B74F60D9-A4B5-4967-853C-0D902EFE25D3Q55514036-5A055F3F-3E2F-495D-A9C7-5D6E528DF5C2Q56517232-6DFCD292-55A2-4C2C-8486-FC12EA5C5835Q57072601-4E5F01E8-9BB7-46B4-876A-8D3A2C123975Q57117487-E133E6F9-FF1F-4B7C-94B6-973A1BF08141Q57176511-C7F92C78-E6B4-4A4D-9061-CE41EDC960D7Q58764123-FA0E6183-8305-41E5-8DC5-CCAAC000D7EF
P2860
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Synbiotics Easing Renal Failur ...... (SYNERGY): A Randomized Trial.
@ast
Synbiotics Easing Renal Failur ...... (SYNERGY): A Randomized Trial.
@en
type
label
Synbiotics Easing Renal Failur ...... (SYNERGY): A Randomized Trial.
@ast
Synbiotics Easing Renal Failur ...... (SYNERGY): A Randomized Trial.
@en
prefLabel
Synbiotics Easing Renal Failur ...... (SYNERGY): A Randomized Trial.
@ast
Synbiotics Easing Renal Failur ...... (SYNERGY): A Randomized Trial.
@en
P2093
P2860
P50
P356
P1476
Synbiotics Easing Renal Failur ...... (SYNERGY): A Randomized Trial
@en
P2093
Brett C McWhinney
Cheuk-Chun Szeto
David W Johnson
Elaine M Pascoe
Megan Rossi
P2860
P304
P356
10.2215/CJN.05240515
P577
2016-01-15T00:00:00Z